FCCC LOGO Faculty Publications
Kalemkerian GP , Loo BW Jr , Akerley W , Attia A , Bassetti M , Boumber Y , Decker R , Dobelbower MC , Dowlati A , Downey RJ , Florsheim C , Ganti AKP , Grecula JC , Gubens MA , Hann CL , Hayman JA , Heist RS , Koczywas M , Merritt RE , Mohindra N , Molina J , Moran CA , Morgensztern D , Pokharel S , Portnoy DC , Rhodes D , Rusthoven C , Santana-Davila R , Williams CC Jr , Hoffmann KG , Hughes M
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
J Natl Compr Canc Netw. 2018 Oct;16(10) :1171-1182
PMID: 30323087   
Back to previous list
Abstract
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."
Notes
1540-1413 Kalemkerian, Gregory P Loo, Billy W Jr Akerley, Wallace Attia, Albert Bassetti, Michael Boumber, Yanis Decker, Roy Dobelbower, M Chris Dowlati, Afshin Downey, Robert J Florsheim, Charles Ganti, Apar Kishor P Grecula, John C Gubens, Matthew A Hann, Christine L Hayman, James A Heist, Rebecca Suk Koczywas, Marianna Merritt, Robert E Mohindra, Nisha Molina, Julian Moran, Cesar A Morgensztern, Daniel Pokharel, Saraswati Portnoy, David C Rhodes, Deborah Rusthoven, Chad Santana-Davila, Rafael Williams, Charles C Jr Hoffmann, Karin G Hughes, Miranda Journal Article United States J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182. doi: 10.6004/jnccn.2018.0079.